TY - JOUR AU - Levine, J. S. AU - Branch, D. W. AU - Rauch, J. PY - 2002 DA - 2002// TI - The antiphospholipid syndrome JO - N Eng J Med VL - 346 UR - https://doi.org/10.1056/NEJMra002974 DO - 10.1056/NEJMra002974 ID - Levine2002 ER - TY - JOUR AU - Robertson, B. AU - Greaves, M. PY - 2006 DA - 2006// TI - Antiphospholipid syndrome: an evolving story JO - Blood reviews VL - 20 UR - https://doi.org/10.1016/j.blre.2005.12.001 DO - 10.1016/j.blre.2005.12.001 ID - Robertson2006 ER - TY - JOUR AU - Wilson, W. A. AU - Gharavi, A. E. AU - Koike, T. AU - Locksin, M. D. AU - Branch, D. W. AU - Piette, J. C. AU - Brey, R. AU - Derksen, R. AU - Harris, E. N. AU - Hughes, G. R. AU - Triplett, D. A. AU - Khamashta, M. A. PY - 1999 DA - 1999// TI - International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop JO - Arthritis Rheum VL - 42 UR - https://doi.org/3.0.CO;2-F DO - 3.0.CO;2-F ID - Wilson1999 ER - TY - JOUR AU - Miyakis, S. AU - Lockshin, M. D. AU - Atsumi, T. AU - Branch, D. W. AU - Brey, R. L. AU - Cervera, R. AU - Derksen, R. H. AU - de Groot, P. G. AU - Koike, T. AU - Meroni, P. L. AU - Reber, G. AU - Shoenfeld, Y. AU - Tincani, A. AU - Vlachoyiannopoulos, P. G. AU - Krilis, S. A. PY - 2006 DA - 2006// TI - International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) JO - J Thromb Haemost VL - 4 UR - https://doi.org/10.1111/j.1538-7836.2006.01753.x DO - 10.1111/j.1538-7836.2006.01753.x ID - Miyakis2006 ER - TY - JOUR AU - Perez-Vasquez, M. E. AU - Villa, A. R. AU - Drenkard, C. AU - Cabiedes, J. AU - Alarcón-Segovia, D. PY - 1993 DA - 1993// TI - Influence of disease duration, continued follow up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with SLE JO - J Rheumatol VL - 20 ID - Perez-Vasquez1993 ER - TY - JOUR AU - Ginsberg, J. S. AU - Wells, P. S. AU - Brill-Edwards, P. AU - Donovan, D. AU - Moffatt, K. AU - Johnston, M. AU - Stevens, P. AU - Hirsh, J. PY - 1995 DA - 1995// TI - Antiphospholipid antibodies and venous thromboembolism JO - Blood VL - 86 ID - Ginsberg1995 ER - TY - JOUR AU - Lim, W. AU - Crowther, M. A. AU - Eikelboom, J. W. PY - 2006 DA - 2006// TI - Management of antiphospholipid antibody syndrome – a systematic review JO - JAMA VL - 295 UR - https://doi.org/10.1001/jama.295.9.1050 DO - 10.1001/jama.295.9.1050 ID - Lim2006 ER - TY - JOUR AU - Petri, M. PY - 2000 DA - 2000// TI - Epidemiology of the antiphospholipid antibody syndrome JO - J Autoimmun VL - 15 UR - https://doi.org/10.1006/jaut.2000.0409 DO - 10.1006/jaut.2000.0409 ID - Petri2000 ER - TY - JOUR AU - Nencini, P. AU - Baruffi, M. C. AU - Abbate, R. AU - Massai, G. AU - Amaducci, L. AU - Inzitari, D. PY - 1992 DA - 1992// TI - Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischaemia JO - Stroke VL - 23 UR - https://doi.org/10.1161/01.STR.23.2.189 DO - 10.1161/01.STR.23.2.189 ID - Nencini1992 ER - TY - JOUR AU - Galli, M. AU - Luciani, D. AU - Bertolini, G. AU - Barbui, T. PY - 2003 DA - 2003// TI - Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature JO - Blood VL - 101 UR - https://doi.org/10.1182/blood-2002-02-0441 DO - 10.1182/blood-2002-02-0441 ID - Galli2003 ER - TY - JOUR AU - Wahl, D. G. AU - Guillemin, F. AU - De Maistre, E. AU - Perret-Guillaume, C. AU - Lecompte, T. AU - Thibaut, G. PY - 1998 DA - 1998// TI - Meta – analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis JO - Lupus VL - 7 UR - https://doi.org/10.1191/096120398678919688 DO - 10.1191/096120398678919688 ID - Wahl1998 ER - TY - JOUR AU - Wahl, D. G. AU - Guillemin, F. AU - De Maistre, E. AU - Perret-Guillaume, C. AU - Lecompte, T. AU - Thibaut, G. PY - 1997 DA - 1997// TI - Risk of venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus – a meta – analysis JO - Lupus VL - 6 UR - https://doi.org/10.1177/096120339700600510 DO - 10.1177/096120339700600510 ID - Wahl1997 ER - TY - JOUR AU - Rosove, M. H. AU - Brewer, P. M. PY - 1992 DA - 1992// TI - Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients JO - Ann Intern Med VL - 117 UR - https://doi.org/10.7326/0003-4819-117-4-303 DO - 10.7326/0003-4819-117-4-303 ID - Rosove1992 ER - TY - JOUR AU - Derksen, R. AU - de Groot, P. G. AU - Kater, L. AU - Nieuwenhuis, H. K. PY - 1993 DA - 1993// TI - Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment JO - Ann Rheum Dis VL - 52 UR - https://doi.org/10.1136/ard.52.9.689 DO - 10.1136/ard.52.9.689 ID - Derksen1993 ER - TY - JOUR AU - Khamashta, M. A. AU - Cuadrado, M. J. AU - Mujic, F. AU - Taub, N. A. AU - Hunt, B. J. AU - Hughes, G. R. PY - 1995 DA - 1995// TI - The management of thrombosis in the antiphospholipid antibody syndrome JO - N Eng J Med VL - 332 UR - https://doi.org/10.1056/NEJM199504133321504 DO - 10.1056/NEJM199504133321504 ID - Khamashta1995 ER - TY - STD TI - Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004, 126 (3 Suppl): 401S-512S. ID - ref16 ER - TY - CHAP AU - Ortel, T. L. PY - 2005 DA - 2005// TI - Thrombosis and the antiphospholipid syndrome BT - Hematology ID - Ortel2005 ER - TY - JOUR AU - Meroni, P. L. AU - Moia, M. AU - Derksen, R. H. AU - Tincani, A. AU - McIntyre, J. A. AU - Arnaut, J. M. AU - Koike, T. AU - Piette, J. C. AU - Khamashta, M. A. AU - Shoenfeld, Y. PY - 2003 DA - 2003// TI - Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis JO - Lupus VL - 12 UR - https://doi.org/10.1191/0961203303lu389oa DO - 10.1191/0961203303lu389oa ID - Meroni2003 ER - TY - JOUR AU - Derksen, R. AU - de Groot, P. G. PY - 2000 DA - 2000// TI - Do we know which patients with the antiphospholipid syndrome should receive long term high dose anticoagulation? JO - J Autoimmunity VL - 15 UR - https://doi.org/10.1006/jaut.2000.0395 DO - 10.1006/jaut.2000.0395 ID - Derksen2000 ER - TY - JOUR AU - Crowther, M. A. PY - 2004 DA - 2004// TI - Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome JO - Thrombosis Research VL - 114 UR - https://doi.org/10.1016/j.thromres.2004.06.011 DO - 10.1016/j.thromres.2004.06.011 ID - Crowther2004 ER - TY - JOUR AU - Erkan, D. AU - Ortel, T. L. AU - Lockshin, M. D. PY - 2005 DA - 2005// TI - Warfarin in the antiphospholipid syndrome – time to explore new horizons JO - J Rheumatol VL - 32 ID - Erkan2005 ER - TY - JOUR AU - Finazzi, G. AU - Brancaccio, V. AU - Moia, M. AU - Ciaverella, N. AU - Mazzucconi, M. G. AU - Schinco, P. G. AU - Ruggeri, M. AU - Pogliani, E. M. AU - Gamba, G. AU - Rossi, E. AU - Baudo, F. AU - Manotti, C. AU - D'Angelo, A. AU - Palareti, G. AU - De Stefano, V. AU - Berrettini, M. AU - Barbui, T. PY - 1996 DA - 1996// TI - Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four year prospective study from the Italian registry JO - Am J Med VL - 100 UR - https://doi.org/10.1016/S0002-9343(96)00060-5 DO - 10.1016/S0002-9343(96)00060-5 ID - Finazzi1996 ER - TY - JOUR AU - Turiel, M. AU - Sarzi-Puttini, P. AU - Peretti, R. AU - Rossi, E. AU - Atzeni, F. AU - Parsons, W. AU - Doria, A. PY - 2005 DA - 2005// TI - Thrombotic risk factors in primary antiphospholipid syndrome: a 5 year prospective study JO - Stroke VL - 36 UR - https://doi.org/10.1161/01.STR.0000170645.40562.09 DO - 10.1161/01.STR.0000170645.40562.09 ID - Turiel2005 ER - TY - JOUR AU - Kearon, C. AU - Gent, M. AU - Hirsh, J. AU - Weitz, J. AU - Kovacs, M. J. AU - Anderson, D. R. AU - Turpie, A. G. AU - Green, D. AU - Ginsberg, J. S. AU - Wells, P. AU - Mackinnon, B. AU - Julian, J. A. PY - 1999 DA - 1999// TI - A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism JO - N Eng J Med VL - 340 UR - https://doi.org/10.1056/NEJM199903253401201 DO - 10.1056/NEJM199903253401201 ID - Kearon1999 ER - TY - JOUR AU - Schulman AU - Svenungsson, E. AU - Granqvist, S. PY - 1998 DA - 1998// TI - Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group JO - Am J Med VL - 104 UR - https://doi.org/10.1016/S0002-9343(98)00060-6 DO - 10.1016/S0002-9343(98)00060-6 ID - Schulman1998 ER - TY - JOUR AU - Schulman, S. AU - Lindmarker, P. AU - Holmström, M. AU - Lärfars, G. AU - Carlsson, A. AU - Nicol, P. AU - Svensson, E. AU - Ljungberg, B. AU - Viering, S. AU - Norlander, S. AU - Leijd, B. AU - Jahed, K. AU - Hjorth, M. AU - Linder, O. AU - Beckman, M. PY - 2006 DA - 2006// TI - Post – thrombotic syndrome, recurrence and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months JO - J Thromb Haemost VL - 4 UR - https://doi.org/10.1111/j.1538-7836.2006.01795.x DO - 10.1111/j.1538-7836.2006.01795.x ID - Schulman2006 ER - TY - JOUR AU - Pinede, J. AU - Duhaut, P. AU - Cucherat, M. AU - Ninet, J. AU - Pasquier, J. AU - Boissel, J. P. PY - 2000 DA - 2000// TI - Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta – analysis of randomized, controlled trials JO - J Intern Med VL - 247 UR - https://doi.org/10.1046/j.1365-2796.2000.00631.x DO - 10.1046/j.1365-2796.2000.00631.x ID - Pinede2000 ER - TY - JOUR AU - Ost, D. AU - Tepper, J. AU - Mihara, H. AU - Lander, O. AU - Heinzer, R. AU - Fein, A. PY - 2005 DA - 2005// TI - Duration of anticoagulation following venous thromboembolism: a meta – analysis JO - JAMA VL - 294 UR - https://doi.org/10.1001/jama.294.6.706 DO - 10.1001/jama.294.6.706 ID - Ost2005 ER - TY - JOUR AU - van Dongen, C. J. AU - Vink, R. AU - Hutten, B. A. AU - Buller, H. R. AU - Prins, M. H. PY - 2003 DA - 2003// TI - The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event JO - Arch Intern Med VL - 163 UR - https://doi.org/10.1001/archinte.163.11.1285 DO - 10.1001/archinte.163.11.1285 ID - van Dongen2003 ER - TY - JOUR AU - Crowther, M. A. AU - Ginsberg, J. S. AU - Julian, J. AU - Denburg, J. AU - Hirsh, J. AU - Douketis, J. AU - Laskin, C. AU - Fortin, P. AU - Anderson, D. AU - Kearon, C. AU - Clarke, A. AU - Geerts, W. AU - Forgie, M. AU - Green, D. AU - Constantini, L. AU - Yacura, W. AU - Wilson, S. AU - Gent, M. AU - Kovacs, M. J. PY - 2003 DA - 2003// TI - A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome JO - N Eng J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa035241 DO - 10.1056/NEJMoa035241 ID - Crowther2003 ER - TY - JOUR AU - Sacco, R. L. AU - Adams, R. AU - Albers, G. AU - Alberts, M. J. AU - Benavente, O. AU - Karen, F. AU - Goldstein, L. B. AU - Gorelick, P. AU - Halperin, J. AU - Harbaugh, R. AU - Johnston, S. C. AU - Katzan, I. AU - Kelly-Hayes, M. AU - Kenton, E. J. AU - Marks, M. AU - Schwamm, L. H. AU - Tomsick, T. PY - 2006 DA - 2006// TI - Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack JO - Stroke VL - 37 UR - https://doi.org/10.1161/01.STR.0000199147.30016.74 DO - 10.1161/01.STR.0000199147.30016.74 ID - Sacco2006 ER - TY - STD TI - A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin: The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. Ann Neurol. 1997, 42: 857-65. 10.1002/ana.410420606. ID - ref32 ER - TY - JOUR AU - Verro, P. AU - Levine, S. R. AU - Tietjen, G. E. PY - 1998 DA - 1998// TI - Cerebrovascular ischemic events with high positive anticardiolipin antibodies JO - Stroke VL - 29 UR - https://doi.org/10.1161/01.STR.29.11.2245 DO - 10.1161/01.STR.29.11.2245 ID - Verro1998 ER - TY - JOUR AU - Brey, R. L. PY - 2004 DA - 2004// TI - Management of the neurological manifestations of APS – what do the trials tell us? JO - Thromb Research VL - 114 UR - https://doi.org/10.1016/j.thromres.2004.06.018 DO - 10.1016/j.thromres.2004.06.018 ID - Brey2004 ER - TY - JOUR AU - Ruiz-Irastorza, G. AU - Khamashta, M. A. AU - Hunt, B. J. AU - Escudero, A. AU - Cuadrado, M. J. AU - Hughes, G. R. PY - 2002 DA - 2002// TI - Bleeding and recurrent thrombosis in definite antiphospholipid syndrome JO - Arch Intern Med VL - 162 UR - https://doi.org/10.1001/archinte.162.10.1164 DO - 10.1001/archinte.162.10.1164 ID - Ruiz-Irastorza2002 ER - TY - JOUR AU - Derksen, R. AU - de Groot, P. G. AU - Kappelle, L. J. PY - 2003 DA - 2003// TI - Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome JO - Neurology VL - 61 UR - https://doi.org/10.1212/01.WNL.0000072324.59029.92 DO - 10.1212/01.WNL.0000072324.59029.92 ID - Derksen2003 ER - TY - JOUR PY - 2004 DA - 2004// TI - Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke JO - JAMA VL - 291 UR - https://doi.org/10.1001/jama.291.5.576 DO - 10.1001/jama.291.5.576 ID - ref37 ER - TY - JOUR AU - Erkan, D. AU - Lockshin, M. D. PY - 2004 DA - 2004// TI - How much warfarin is enough in APS related thrombosis? JO - Thromb Research VL - 114 UR - https://doi.org/10.1016/j.thromres.2004.06.010 DO - 10.1016/j.thromres.2004.06.010 ID - Erkan2004 ER - TY - JOUR AU - Wells, P. S. AU - Holbrook, A. M. AU - Crowther, M. AU - Hirsh, J. PY - 1994 DA - 1994// TI - Interactions of warfarin with drugs and food JO - Ann Intern Med VL - 121 UR - https://doi.org/10.7326/0003-4819-121-9-199411010-00009 DO - 10.7326/0003-4819-121-9-199411010-00009 ID - Wells1994 ER - TY - JOUR AU - Kaul, M. AU - Erkan, D. AU - Artim-Esen, B. AU - Diz-Kucukkaya, R. AU - Inanc, M. AU - Lockshin, M. D. PY - 2005 DA - 2005// TI - Warfarin alternatives for secondary thrombosis prophylaxis in antiphospholipid syndrome (APS) JO - Arthritis Rheum VL - 52 ID - Kaul2005 ER - TY - JOUR AU - Erkan, D. AU - Harrison, M. J. AU - Levy, R. AU - Peterson, M. AU - Petri, M. AU - Sammaritano, L. AU - Unalp-Arida, A. AU - Vilela, V. AU - Yazici, Y. AU - Lockshin, M. D. PY - 2007 DA - 2007// TI - Aspirin for primary thrombosis prevention in the antiphospholipid syndrome JO - Arthritis Rheum VL - 56 UR - https://doi.org/10.1002/art.22663 DO - 10.1002/art.22663 ID - Erkan2007 ER - TY - JOUR AU - Kher, A. AU - Samama, M. M. PY - 2005 DA - 2005// TI - Primary and secondary prophylaxis of venous thromboembolism with low molecular weight heparins: prolonged thromboprophylaxis, an alternative to vitamin K antagonists JO - J Thromb Haemost VL - 3 UR - https://doi.org/10.1111/j.1538-7836.2005.01180.x DO - 10.1111/j.1538-7836.2005.01180.x ID - Kher2005 ER - TY - JOUR AU - Hull, R. AU - Pineo, G. F. AU - Brant, R. F. AU - Mah, A. F. AU - Bruke, N. AU - Dear, R. AU - Wong, T. AU - Cook, R. AU - Solymoss, S. AU - Poon, M. C. AU - Raskob, G. PY - 2007 DA - 2007// TI - Self managed long term low molecular weight heparin: the balance of benefits and harms JO - Am J Med VL - 120 UR - https://doi.org/10.1016/j.amjmed.2006.03.030 DO - 10.1016/j.amjmed.2006.03.030 ID - Hull2007 ER - TY - JOUR AU - Dentali, F. AU - Manfredi, E. AU - Crowther, M. AU - Ageno, W. PY - 2005 DA - 2005// TI - Long duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy JO - J Thromb Haemost VL - 3 UR - https://doi.org/10.1111/j.1538-7836.2005.01516.x DO - 10.1111/j.1538-7836.2005.01516.x ID - Dentali2005 ER - TY - JOUR AU - Linkins, L. A. AU - Weitz, J. I. PY - 2003 DA - 2003// TI - New anticoagulants JO - Sem Thromb Hemost VL - 29 UR - https://doi.org/10.1055/s-2004-815629 DO - 10.1055/s-2004-815629 ID - Linkins2003 ER - TY - JOUR AU - Weitz, J. I. PY - 2006 DA - 2006// TI - Emerging anticoagulants for the treatment of venous thromboembolism JO - Thromb Haemost VL - 96 ID - Weitz2006 ER - TY - JOUR AU - Eriksson, B. I. AU - Dahl, O. E. AU - Rosencher, N. AU - Kurth, A. AU - van Dijk, C. N. AU - Frostick, S. P. AU - Kälebo, P. AU - Christiansen, A. V. AU - Hantel, S. AU - Hettiarachchi, R. AU - Schnee, J. AU - Büller, H. R. PY - 2007 DA - 2007// TI - Oral dabigatran etexilate versus subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial JO - J Thromb Haemost VL - 5 UR - https://doi.org/10.1111/j.1538-7836.2007.02748.x DO - 10.1111/j.1538-7836.2007.02748.x ID - Eriksson2007 ER - TY - JOUR AU - Eriksson, B. I. AU - Dahl, O. E. AU - Rosencher, N. AU - Kurth, A. AU - Van Dijk, C. N. AU - Frostick, S. P. AU - Prins, M. H. AU - Hettiarachchi, R. AU - Hantel, S. AU - Schnee, J. AU - Büller, H. R. PY - 2007 DA - 2007// TI - Dabigatran etexilate versus enoxaparin for pevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial JO - Lancet VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)61445-7 DO - 10.1016/S0140-6736(07)61445-7 ID - Eriksson2007 ER - TY - JOUR AU - Lassen, M. R. AU - Ageno, W. AU - Borris, L. C. AU - Lieberman, J. R. AU - Rosencher, N. AU - Bandel, T. J. AU - Misselwitz, F. AU - Turpie, A. G. PY - 2008 DA - 2008// TI - Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty JO - N Eng J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa076016 DO - 10.1056/NEJMoa076016 ID - Lassen2008 ER - TY - JOUR AU - Eriksson, B. I. AU - Borris, L. C. AU - Friedman, R. J. AU - Haas, S. AU - Huisman, M. V. AU - Kakkar, A. K. AU - Bandel, T. J. AU - Beckmann, H. AU - Muehlhofer, E. AU - Misselwitz, F. AU - Geerts, W. PY - 2008 DA - 2008// TI - Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip arthroplasty JO - N Eng J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa0800374 DO - 10.1056/NEJMoa0800374 ID - Eriksson2008 ER - TY - CHAP PY - 2008 DA - 2008// BT - NICE technology appraisal guidance 157: Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults ID - ref51 ER - TY - JOUR AU - Roubey, R. A. PY - 2003 DA - 2003// TI - New approaches to prevention of thrombosis in the antiphospholipid syndrome: hopes, trials and tribulations JO - Arthritis Rheum VL - 48 UR - https://doi.org/10.1002/art.11332 DO - 10.1002/art.11332 ID - Roubey2003 ER - TY - JOUR AU - Meroni, P. L. AU - Raschi, E. AU - Testoni, C. AU - Tincani, A. AU - Balestrieri, G. AU - Molteni, R. AU - Khamashta, M. A. AU - Tremoli, E. AU - Camera, M. PY - 2001 DA - 2001// TI - Statins prevent endothelial cell activation induced by antiphospholipid (anti-β2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype JO - Arthritis Rheum VL - 44 UR - https://doi.org/3.0.CO;2-Y DO - 3.0.CO;2-Y ID - Meroni2001 ER - TY - JOUR AU - Rubenstein, E. AU - Arkfeld, D. G. AU - Metyas, S. AU - Shinada, S. AU - Ehresmann, S. AU - Libman, H. A. PY - 2006 DA - 2006// TI - Rituximab treatment for resistant antiphospholipid syndrome JO - J Rheumatol VL - 33 ID - Rubenstein2006 ER - TY - JOUR AU - Tenedios, F. AU - Erkan, D. AU - Lockshin, M. D. PY - 2005 DA - 2005// TI - Rituximab in the primary antiphospholipid syndrome (PAPS) JO - Arthritis Rheum VL - 52 ID - Tenedios2005 ER - TY - CHAP AU - Lopez, J. A. AU - Kearon, C. AU - Lee, A. Y. PY - 2004 DA - 2004// TI - Deep vein thrombosis BT - Hematology Am Soc Hematol Edu Program ID - Lopez2004 ER - TY - JOUR AU - Schulman, S. AU - Ogren, M. PY - 2006 DA - 2006// TI - New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism JO - Thromb Haemost VL - 96 ID - Schulman2006 ER - TY - JOUR AU - Baglin, T. AU - Luddington, R. AU - Brown, K. AU - Baglin, C. PY - 2003 DA - 2003// TI - Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study JO - Lancet VL - 362 UR - https://doi.org/10.1016/S0140-6736(03)14111-6 DO - 10.1016/S0140-6736(03)14111-6 ID - Baglin2003 ER - TY - JOUR AU - Petri, M. PY - 2005 DA - 2005// TI - Lupus in Baltimore: evidence – based «clinical pearls» from the Hopkins Lupus Cohort JO - Lupus VL - 14 UR - https://doi.org/10.1191/0961203305lu2230xx DO - 10.1191/0961203305lu2230xx ID - Petri2005 ER - TY - JOUR AU - Petri, M. PY - 2000 DA - 2000// TI - Hopkins Lupus Cohort:1999 update JO - Rheum Dis Clin North Am VL - 26 UR - https://doi.org/10.1016/S0889-857X(05)70135-6 DO - 10.1016/S0889-857X(05)70135-6 ID - Petri2000 ER - TY - JOUR AU - Calvo-Alén, J. AU - Toloza, S. M. AU - Fernández, M. AU - Bastian, H. M. AU - Fessler, B. J. AU - Roseman, J. M. AU - McGwin, G. AU - Vilá, L. M. AU - Reveille, J. D. AU - Alarcón, G. S. PY - 2005 DA - 2005// TI - Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): smoking, older age, disease activity, lupus anticoagulant and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients JO - Arth Rheum VL - 52 UR - https://doi.org/10.1002/art.21149 DO - 10.1002/art.21149 ID - Calvo-Alén2005 ER - TY - JOUR AU - Merkel, P. A. AU - Lo, G. H. AU - Holbrook, J. T. AU - Tibbs, A. K. AU - Allen, N. B. AU - Davis, J. C. AU - Hoffman, G. S. AU - McCune, W. S. AU - St Clair, E. W. AU - Specks, U. AU - Spiera, R. AU - Petri, M. AU - Stone, J. H. PY - 2005 DA - 2005// TI - Brief communication: high incidence of venous thrombotic events among patients with Wegener Granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study JO - Ann Intern Med VL - 142 UR - https://doi.org/10.7326/0003-4819-142-8-200505030-00011 DO - 10.7326/0003-4819-142-8-200505030-00011 ID - Merkel2005 ER - TY - JOUR AU - Rees, J. D. AU - Lança, S. AU - Marques, P. V. AU - Gómez-Puerta, J. A. AU - Moco, R. AU - Oliveri, C. AU - Khamashta, M. A. AU - Hughes, G. R. AU - D'Cruz, D. P. PY - 2006 DA - 2006// TI - Prevalence of the antiphospholipid syndrome in primary systemic vasculitis JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2004.034231 DO - 10.1136/ard.2004.034231 ID - Rees2006 ER - TY - JOUR AU - Palareti, G. AU - Cosmi, B. AU - Legnani, C. AU - Tosetto, A. AU - Brusi, C. AU - Iono, A. AU - Pengo, V. AU - Ghirarduzzi, A. AU - Pattacini, C. AU - Testa, S. AU - Lensing, A. W. AU - Tripodi, A. AU - PROLONG, I. n. v. e. s. t. i. g. a. t. o. r. s. PY - 2006 DA - 2006// TI - D – Dimer testing to determine the duration of anticoagulation therapy JO - N Eng J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa054444 DO - 10.1056/NEJMoa054444 ID - Palareti2006 ER - TY - JOUR AU - Rosendaal, F. R. AU - van Hylckama Vlieg, A. AU - Tanis, B. C. AU - Helmerhorst, F. M. PY - 2003 DA - 2003// TI - Estrogens, progestogens and thrombosis JO - J Thromb Haemost VL - 1 UR - https://doi.org/10.1046/j.1538-7836.2003.00264.x DO - 10.1046/j.1538-7836.2003.00264.x ID - Rosendaal2003 ER - TY - JOUR AU - Girolami, A. AU - Zanoni, E. AU - Zanardi, S. AU - Saracino, M. A. AU - Simioni, P. PY - 1996 DA - 1996// TI - Thromboembolic disease developing during oral contraceptive therapy in young femeales with antiphospholipid antibodies JO - Blood Coagu Fibrinolysis VL - 7 UR - https://doi.org/10.1097/00001721-199606000-00011 DO - 10.1097/00001721-199606000-00011 ID - Girolami1996 ER - TY - CHAP AU - Macik, B. J. AU - Rand, J. H. AU - Konkle, B. A. PY - 2001 DA - 2001// TI - Thrombophilia: what's a practitioner to do? BT - Hematology Am Soc Hematol Edu Program ID - Macik2001 ER - TY - JOUR AU - Lakasing, L. AU - Khamashta, M. A. PY - 2001 DA - 2001// TI - Contraceptive practices in women with systemic lupus erythematosus and/or antiphospholipid syndrome: what advice should we be giving? JO - J Fam Plan Reprod Health Care VL - 27 UR - https://doi.org/10.1783/147118901101195029 DO - 10.1783/147118901101195029 ID - Lakasing2001 ER - TY - CHAP AU - Bank, I. AU - Middledorp, S. AU - Prins, M. H. ED - Brenner, B. ED - Marder, V. J. ED - Conard, J. PY - 2002 DA - 2002// TI - Oral contraceptives and cardiovascular disease BT - Women's Issues in Thrombosis and Haemostasis ID - Bank2002 ER - TY - JOUR AU - Winkler, U. H. AU - Howie, H. AU - Bühler, K. AU - Korver, T. AU - Geurts, T. B. AU - Coelingh Bennink, H. J. PY - 1998 DA - 1998// TI - A randomized double blind study of the effects of two progestogen only pills containing 75 microgam desogestrel or 3 microgram levonorgestrel JO - Contraception VL - 57 UR - https://doi.org/10.1016/S0010-7824(98)00045-6 DO - 10.1016/S0010-7824(98)00045-6 ID - Winkler1998 ER - TY - JOUR AU - Conard, J. AU - Plu-Bureau, G. AU - Bahi, N. AU - Horellou, M. H. AU - Pelissier, C. AU - Thalabard, J. C. PY - 2004 DA - 2004// TI - Progestogen only contraception in women at high risk of venous thromboembolism JO - Contraception VL - 70 UR - https://doi.org/10.1016/j.contraception.2004.07.009 DO - 10.1016/j.contraception.2004.07.009 ID - Conard2004 ER - TY - STD TI - World Health Oraganization Collaborative Study of cardiovascular disease and steroid hormone contraception. Contraception. 1998, 57: 315-24. 10.1016/S0010-7824(98)00041-9. ID - ref72 ER - TY - STD TI - Royal College of Obstetricians and Gynaecologists. Venous thromboembolism and hormonal contraception. 2004, 1-13. ID - ref73 ER - TY - JOUR AU - Rondina, M. T. AU - Pendleton, R. C. AU - Wheeler, M. AU - Rodgers, G. M. PY - 2007 DA - 2007// TI - The treatment of venous thromboembolism in special populations JO - Thrombosis Research VL - 119 UR - https://doi.org/10.1016/j.thromres.2006.05.015 DO - 10.1016/j.thromres.2006.05.015 ID - Rondina2007 ER -